Drug Profile
DM 232
Alternative Names: UnifiramLatest Information Update: 23 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Neuroprotectants; Nootropics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 23 Jun 2000 Preclinical development for Alzheimer's disease in Italy (Unknown route)